» Articles » PMID: 39863932

TRAF1 Promotes Osteoclastogenesis by Enhancing Metabolic Adaptation to Oxidative Phosphorylation in an AKT-dependent Manner

Overview
Journal Mol Ther
Publisher Cell Press
Date 2025 Jan 26
PMID 39863932
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor receptor-associated factor 1 (TRAF1) is a crucial signaling adaptor involved in multiple cellular events. However, its role in regulating osteoclastogenesis and energy metabolism remains unclear. Here, we report that TRAF1 promotes osteoclastogenesis and oxidative phosphorylation (OXPHOS). Employing RNA sequencing, we found that TRAF1 is markedly upregulated during osteoclastogenesis and is positively associated with osteoporosis. TRAF1 knockout inhibits osteoclastogenesis and increases bone mass in both normal and ovariectomized adult mice without affecting bone mass in childhood. Furthermore, TRAF1 promotes osteoclast OXPHOS by increasing the phosphorylation level of AKT. Mechanistically, TRAF1 functions to inhibit TRAF2-induced ubiquitination of Gβl, a known activator of AKT, and further upregulates AKT phosphorylation. Rescue experiments revealed that the inhibitory effects of TRAF1 knockout on osteoclastogenesis, OXPHOS, and bone mass are dependent on AKT. Collectively, our findings uncover a previously unrecognized function of TRAF1 in regulating osteoclastogenesis and energy metabolism, and establish a novel TRAF1-AKT-OXPHOS axis in osteoclasts.

References
1.
Park-Min K . Metabolic reprogramming in osteoclasts. Semin Immunopathol. 2019; 41(5):565-572. PMC: 7671717. DOI: 10.1007/s00281-019-00757-0. View

2.
Wang Y, Mikhailova M, Bose S, Pan C, deVere White R, Ghosh P . Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival. Oncogene. 2008; 27(56):7106-17. PMC: 2694040. DOI: 10.1038/onc.2008.318. View

3.
Wang B, Jie Z, Joo D, Ordureau A, Liu P, Gan W . TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature. 2017; 545(7654):365-369. PMC: 5695540. DOI: 10.1038/nature22344. View

4.
Walker M, Shane E . Postmenopausal Osteoporosis. N Engl J Med. 2023; 389(21):1979-1991. DOI: 10.1056/NEJMcp2307353. View

5.
Wi D, Wilson A, Satge F, Murrell D . Psoriasis and osteoporosis: a literature review. Clin Exp Dermatol. 2022; 47(8):1438-1445. PMC: 9543251. DOI: 10.1111/ced.15174. View